MK-677 Side Effects
MK-677 (ibutamoren) is an oral ghrelin-receptor agonist. Its side-effect profile is the most pronounced of the GH-axis compounds: appetite, fluid retention, and a real insulin-resistance signal at longer durations.
When they appear & how long they last
Appetite and water retention appear quickly - often within days. The metabolic effects (fasting glucose, insulin) build over weeks to months, which is the key monitoring concern.
Commonly reported MK-677 side effects
The signature MK-677 effect - strong ghrelin-receptor stimulation.
Noticeable fluid retention, often in hands/feet.
Especially with morning dosing; many shift to bedtime.
Carpal-tunnel-like from fluid retention.
A documented effect that builds with duration - the main concern.
From GH pulses shifting sleep architecture.
When to contact your provider
- Fasting glucose or HbA1c trending into prediabetic range
- Persistent, significant fluid retention
- Numbness/tingling that does not resolve
- Rapid resting heart-rate increase
Biomarkers worth tracking on MK-677
These catch issues early - before you feel them. Pull a baseline before you start, then re-check on the cadence noted below.
THE marker for MK-677 - it reliably nudges glucose up over time.
Catches the insulin-resistance drift before glucose moves.
90-day glycemic average - the durability check.
Confirms the GH-axis response.
How to actually track MK-677 side effects
MK-677 is the GH compound where tracking is non-negotiable: the insulin-resistance signal is real and builds over months. Pull fasting glucose, fasting insulin, and HbA1c at baseline, then quarterly while on it. A 30%+ upward drift in fasting insulin or glucose creeping out of range is the signal to re-evaluate - and you only see it if you have the baseline.
Track MK-677 with MyProtocolStack →